Dr. John Krystal M.D.
Director, Science Advisory Board
Dr. Krystal is the Robert L. McNeil, Jr., Professor of Translational Research and Chair of the Department of Psychiatry of the Yale University School of Medicine and Chief of Psychiatry at Yale-New Haven Hospital. He is a graduate of the University of Chicago, Yale University School of Medicine, and the Yale Psychiatry Residency Training Program. He has published over 400 papers and reviews on the neurobiology and treatment of alcoholism, schizophrenia, post-traumatic stress disorder, and depression. Dr. Krystal’s research program unites psychopharmacology, neuroimaging, and molecular genetics. His work on brain glutamate systems contributed to the identification of novel treatment mechanisms for alcoholism, depression, and schizophrenia that are now in development. Dr. Krystal is the Director of the NIAAA Center for the Translational Neuroscience of Alcoholism and the Clinical Neuroscience Division of the VA National Center for PTSD.
Dr. Krystal received a number of awards including the Joel Elkes Award of the American College of Neuropsychopharmacology, the Anna-Monika Foundation Prize for Depression Research, and the NIAAA Jack Mendelson Alcoholism Research Award. He is also a member of the Institute of Medicine of the U.S. National Academy of Sciences. He was Chairman of the NIMH Board of Scientific Counselors (2004-2007), served on the NIAAA National Alcohol Advisory Council (2008-2012), and president of the American College of Neuropsychopharmacology (2012). Since 2006, he has edited a leading psychiatry and neuroscience journal, Biological Psychiatry.
Professor of Translational Research and Chair of the Department of Psychiatry of the Yale University School of Medicine and Chief of Psychiatry at Yale-New Haven Hospital